+351 211 369 829 
Global Fatty Liver Day – 12th June 2025
Fatty liver disease is a metabolic dysfunction that affects approximately one in every four adults and is particularly common among individuals with d
Ophiomics @ EASL Congress 2025 in Amsterdam 🌷
We had the opportunity to showcase HepatoPredict and introduce our future screening tools for Hepatocellular Carcinoma (HCC) and MASLD. It’s excitin
World Liver Day – The time for Precision Liver Medicine is now
The Time for Precision Liver Medicine is Now Precision Liver Medicine is transforming how we tackle the growing burden of chronic liver diseases. Cond
Introducing LiverSphere: A Smarter Way to Work with Liver Research Data
Introducing LiverSphere: A Smarter Way to Work with Liver Research Data Over the past few years, SpecimensDB has been our trusted internal platform fo
LEOPARD Project’s First Annual Meeting in Lisbon
Ophiomics was delighted to host the LEOPARD Project’s First Annual Meeting in Lisbon last week! We’re proud to share a common mission with our
Ophiomics @ EASL Liver Cancer Summit Paris 2025
We truly enjoyed our time at the EASL Liver Cancer Summit Paris 2025! Over two and a half days, we engaged in insightful discussions and attended outs
Advancing Clinical Validation: A New Milestone for HepatoPredict
We are thrilled to announce that an important clinical validation of our Hepatocellular carcinoma (HCC) prognostic tool, HepatoPredict, has been publi
Medlab Middle East 2025
Ophiomics will be present @ Medlab Middle East to support our efforts of entering new markets. Contact us if you want to discuss new business opportun
Major milestones that have shaped our journey in 2024
As we kick off 2025, we’re proud to reflect on some major milestones that have shaped our journey in 2024: EASL Congress & EASL Liver Cancer
BioJapan 2024
Ophiomics was present in BioJapan 2024 in Yokohama. It was great to meet old and new friends and to discuss avenues for collaboration with Japanese (a
